Harbour BioMed receives FDA approval of Investigational New Drug application

06 April 2021 | PlantForm announced it has reached a collaborative research and development agreement with Bio-Manguinhos/Fiocruz to develop a...

29 March 2021 | Samsung Bioepis announced on 29 March 2021 that it has launched Hadlima®, its 50mg/mL biosimilar adalimumab in Australia and Canada....

24 March 2021 | EirGenix announced that its Ph III clinical trial of EG12014 (proposed trastuzumab biosimilar) has met its primary endpoint....

15 March 2021 | Alvotech announced it has completed a second round of its US$100 million private placement.  In the first round, Alvotech raised...